These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: conclusions from double-transgenic mouse models. Hübener J; Riess O Neurobiol Dis; 2010 Apr; 38(1):116-24. PubMed ID: 20079840 [TBL] [Abstract][Full Text] [Related]
46. The importance of serine 776 in Ataxin-1 partner selection: a FRET analysis. Menon RP; Soong D; de Chiara C; Holt MR; Anilkumar N; Pastore A Sci Rep; 2012; 2():919. PubMed ID: 23213356 [TBL] [Abstract][Full Text] [Related]
47. Direct and accurate measurement of CAG repeat configuration in the ataxin-1 (ATXN-1) gene by "dual-fluorescence labeled PCR-restriction fragment length analysis". Lin JX; Ishikawa K; Sakamoto M; Tsunemi T; Ishiguro T; Amino T; Toru S; Kondo I; Mizusawa H J Hum Genet; 2008; 53(4):287-295. PubMed ID: 18301861 [TBL] [Abstract][Full Text] [Related]
48. Reduction of Purkinje cell pathology in SCA1 transgenic mice by p53 deletion. Shahbazian MD; Orr HT; Zoghbi HY Neurobiol Dis; 2001 Dec; 8(6):974-81. PubMed ID: 11741393 [TBL] [Abstract][Full Text] [Related]
49. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice. Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814 [TBL] [Abstract][Full Text] [Related]
50. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Lin X; Antalffy B; Kang D; Orr HT; Zoghbi HY Nat Neurosci; 2000 Feb; 3(2):157-63. PubMed ID: 10649571 [TBL] [Abstract][Full Text] [Related]
51. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Watase K; Weeber EJ; Xu B; Antalffy B; Yuva-Paylor L; Hashimoto K; Kano M; Atkinson R; Sun Y; Armstrong DL; Sweatt JD; Orr HT; Paylor R; Zoghbi HY Neuron; 2002 Jun; 34(6):905-19. PubMed ID: 12086639 [TBL] [Abstract][Full Text] [Related]
52. The ubiquitin-conjugating enzyme UbcH6 regulates the transcriptional repression activity of the SCA1 gene product ataxin-1. Lee S; Hong S; Kang S Biochem Biophys Res Commun; 2008 Aug; 372(4):735-40. PubMed ID: 18519031 [TBL] [Abstract][Full Text] [Related]
53. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Klement IA; Skinner PJ; Kaytor MD; Yi H; Hersch SM; Clark HB; Zoghbi HY; Orr HT Cell; 1998 Oct; 95(1):41-53. PubMed ID: 9778246 [TBL] [Abstract][Full Text] [Related]
54. Mini-review: spinocerebellar ataxias: an update of SCA genes. Trott A; Houenou LJ Recent Pat DNA Gene Seq; 2012 Aug; 6(2):115-21. PubMed ID: 22670601 [TBL] [Abstract][Full Text] [Related]
55. Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1. Chen JM; Chen SK; Jin PP; Sun SC Hum Genomics; 2022 Jul; 16(1):29. PubMed ID: 35906672 [TBL] [Abstract][Full Text] [Related]
56. Identification of genes that modify ataxin-1-induced neurodegeneration. Fernandez-Funez P; Nino-Rosales ML; de Gouyon B; She WC; Luchak JM; Martinez P; Turiegano E; Benito J; Capovilla M; Skinner PJ; McCall A; Canal I; Orr HT; Zoghbi HY; Botas J Nature; 2000 Nov; 408(6808):101-6. PubMed ID: 11081516 [TBL] [Abstract][Full Text] [Related]
57. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. Zu T; Duvick LA; Kaytor MD; Berlinger MS; Zoghbi HY; Clark HB; Orr HT J Neurosci; 2004 Oct; 24(40):8853-61. PubMed ID: 15470152 [TBL] [Abstract][Full Text] [Related]
58. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Lee Y; Samaco RC; Gatchel JR; Thaller C; Orr HT; Zoghbi HY Nat Neurosci; 2008 Oct; 11(10):1137-9. PubMed ID: 18758459 [TBL] [Abstract][Full Text] [Related]
59. Targeting several CAG expansion diseases by a single antisense oligonucleotide. Evers MM; Pepers BA; van Deutekom JC; Mulders SA; den Dunnen JT; Aartsma-Rus A; van Ommen GJ; van Roon-Mom WM PLoS One; 2011; 6(9):e24308. PubMed ID: 21909428 [TBL] [Abstract][Full Text] [Related]
60. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model. Watase K; Gatchel JR; Sun Y; Emamian E; Atkinson R; Richman R; Mizusawa H; Orr HT; Shaw C; Zoghbi HY PLoS Med; 2007 May; 4(5):e182. PubMed ID: 17535104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]